Different expression levels of spartin cause broad spectrum of cellular consequences in human neuroblastoma cells

被引:5
|
作者
Milewska, Malgorzata [1 ]
Byrne, Paula Catherine [1 ]
机构
[1] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Sch Med & Med Sci, Dublin 4, Ireland
基金
爱尔兰科学基金会;
关键词
live cell imaging; mitochondria; neuroblastoma cells; oxidative stress; spartin; Troyer syndrome; PROTEIN SPARTIN; TROYER-SYNDROME; SPG20;
D O I
10.1002/cbin.10472
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Hereditary spastic paraplegia describes a diverse group of neurodegenerative conditions characterised by progressive spasticity and weakness of the lower limbs. Mutations in the SPG20 gene encoding spartin cause an autosomal recessive hereditary spastic paraplegia known as Troyer syndrome. To evaluate the cellular consequences of sustained spartin depletion in neuronal cells, we established several clonal SH-SY5Y cell lines with different level of spartin knockdown. Here, we report that cells with modest spartin downregulation show signs of neuronal differentiation such as increased neuritogenesis and cytoskeleton rearrangement. Interestingly, we also indicate that permanent high level spartin depletion results in impaired cell growth and multiple mitochondrial aberrations, which we speculate, arise as a result of chronic oxidative stress. Our studies demonstrate that the scale of spartin downregulation is the major factor that determines the severity of cellular consequences observed and suggest that there is a critical level of spartin expression which must be maintained for proper cellular functions.
引用
收藏
页码:1007 / 1015
页数:9
相关论文
共 50 条
  • [1] STUDIES ON CELLULAR IMMUNITY TO HUMAN NEUROBLASTOMA CELLS
    HELLSTROM, I
    HELLSTROM, KE
    BILL, AH
    PIERCE, GE
    YANG, PS
    INTERNATIONAL JOURNAL OF CANCER, 1970, 6 (02) : 172 - +
  • [2] Different levels of control prevent interferon-γ-inducible HLA-class II expression in human neuroblastoma cells
    Michela Croce
    Alessandro De Ambrosis
    Maria V Corrias
    Vito Pistoia
    Marzia Occhino
    Raffaella Meazza
    Julien Giron-Michel
    Bruno Azzarone
    Roberto S Accolla
    Silvano Ferrini
    Oncogene, 2003, 22 : 7848 - 7857
  • [3] Different levels of control prevent interferon-γ-inducible HLA-class II expression in human neuroblastoma cells
    Croce, M
    De Ambrosis, A
    Corrias, MV
    Pistoia, V
    Occhino, M
    Meazza, R
    Giron-Michel, J
    Azzarone, B
    Accolla, RS
    Ferrini, S
    ONCOGENE, 2003, 22 (49) : 7848 - 7857
  • [4] Expression of prosalusin in human neuroblastoma cells
    Nakayama, Chisato
    Shichiri, Masayoshi
    Sato, Kengo
    Hirata, Yukio
    PEPTIDES, 2009, 30 (07) : 1362 - 1367
  • [5] The broad spectrum of cytokine gene expression by myoid cells from the human marrow microenvironment
    Sensebe, L
    Deschaseaux, M
    Li, J
    Herve, P
    Charbord, P
    STEM CELLS, 1997, 15 (02) : 133 - 143
  • [6] Expression of different mutant p53 transgenes in neuroblastoma cells leads to different cellular responses to genotoxic agents
    Gangopadhyay, S
    Jalali, F
    Reda, D
    Peacock, J
    Bristow, RG
    Benchimol, S
    EXPERIMENTAL CELL RESEARCH, 2002, 275 (01) : 122 - 131
  • [7] Cellular consequences of the expression of Alzheimer's disease-causing presenilin 1 mutations in human neuroblastoma (SH-SY5Y) cells
    Boyle, John P.
    Hettiarachchi, Nishani T.
    Wilkinson, Jenny A.
    Pearson, Hugh A.
    Scragg, Jason L.
    Lendon, Corinne
    Al-Owaisa, Moza M.
    Kim, Cindy B.
    Myers, David M.
    Warburton, Philip
    Peers, Chris
    BRAIN RESEARCH, 2012, 1443 : 75 - 88
  • [8] ENHANCED EXPRESSION OF THE CELLULAR ONCOGENE MYCN AND PROGRESSION OF HUMAN NEUROBLASTOMA
    SCHWAB, M
    ADVANCES IN ENZYME REGULATION, 1991, 31 : 329 - +
  • [9] Regulation of MYCN expression in human neuroblastoma cells
    Jacobs, Joannes F. M.
    van Bokhoven, Hans
    van Leeuwen, Frank N.
    Hulsbergen-van de Kaa, Christina A.
    de Vries, I. Jolanda M.
    Adema, Gosse J.
    Hoogerbrugge, Peter M.
    de Brouwer, Arjan P. M.
    BMC CANCER, 2009, 9
  • [10] Curcumin is a potent broad spectrum inhibitor of matrix metalloproteinase gene expression in human astroglioma cells
    Kim, SY
    Jung, SH
    Kim, HS
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 337 (02) : 510 - 516